The International Conference on Cellular and Molecular Bioengineering (ICCMB 2009) is the premier forum for the presentation of new advances and research results in the fields of theoretical, experimental, and applied Cellular and Molecular Bioengineering. The conference will bring together leading researchers, engineers and scientists in the domain of interest from around the world.
Nanomaterials - namely materials showing unique size-dependent or mesoscopic properties - have attracted considerable attention during the past several years owing to their interesting chemistry, unique properties and potential applications in fields such as life-sciences, energy harvesting, telecommunication and others. The focus of the conference will be on the preparation and exploitation of nanomaterials. World reknowned experts on various aspects of this very broad and rapidly emerging area have been invited. The program will be interesting for beginners and experts in the field as well as industries already active or interested in these materials. Topics to be covered include, but are not limited to: Synthesis methods for the preparation of nanomaterials (including up-scaling) Modification of nanomaterials (e.g. surface functionalisation of colloidal nanoparticles) Characterisation and exploitation of optical, electrochemical, catalytical and other properties Nanomaterial-based devices Application of nanomaterials in life-sciences Self-assembly
For three decades this biennial meeting has brought prominent senior and younger scientists in all aspects of biology, medicine, physico-chemical and pharmaceutical fields to meet the common interests and goals of better drug therapy using novel strategies of drug delivery and drug carriers. The 2008 meeting will focus on several areas of drug delivery including protein and oligonucleotide/gene delivery, polymers and lipid particles, nano-materials, antibody drug-conjugates and cellular carriers, directed to various targets at multiple levels, as well as multimodal molecular imaging applied to monitoring delivery and therapeutic efficacy. This meeting will also include the approaches of chemical biology and nanotechnology to target and achieve enhanced delivery and therapeutic outcomes.